Evaluation of the effectiveness of the New Instruments of ... - CORDIS
Evaluation of the effectiveness of the New Instruments of ... - CORDIS
Evaluation of the effectiveness of the New Instruments of ... - CORDIS
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
The members <strong>of</strong> <strong>the</strong> Panel<br />
1. Ramon Marimon, chairman<br />
(Pr<strong>of</strong>essor at Universitat Pompeu Fabra, Barcelona)<br />
2. Hans-Jörg Bullinger<br />
(Pr<strong>of</strong>essor, President <strong>of</strong> Fraunh<strong>of</strong>er Gesellschaft, Munich)<br />
3. Elef<strong>the</strong>rios Economou<br />
(Pr<strong>of</strong>essor, President-director General <strong>of</strong> FORTH)<br />
4. Louise Gunning Schepers<br />
(Pr<strong>of</strong>essor <strong>of</strong> Social Medicine, Chairman <strong>of</strong> <strong>the</strong> Board and Dean <strong>of</strong><br />
<strong>the</strong> Academic Medical Centre, University <strong>of</strong> Amsterdam)<br />
5. Janina Jozwiak<br />
(Pr<strong>of</strong>essor <strong>of</strong> Economics, Director <strong>of</strong> <strong>the</strong> Polish Institute for statistics<br />
and Demography, Deputy Chairman <strong>of</strong> <strong>the</strong> Polish Scientific Research<br />
Committee)<br />
6. Bob Keown<br />
(Chairman, Beta Technology Limited)<br />
7. Philippe Kourilsky<br />
(Director General <strong>of</strong> Pasteur Institute, Paris)<br />
8. Berit Svendsen<br />
(Executive Vice-President, CTO and working Chairman <strong>of</strong> Telenor<br />
R&D)<br />
9. Georges Wanet<br />
(Managing Director “1A Conseil" and Pr<strong>of</strong>essor, Solvay Business<br />
School, Brussels)<br />
Alain Denis<br />
Rapporteur, Managing Director <strong>of</strong> Yellow Window Management<br />
Consultants<br />
Spain<br />
Germany<br />
Greece<br />
Ne<strong>the</strong>rlands<br />
Poland<br />
United<br />
Kingdom<br />
France<br />
Norway<br />
Belgium<br />
Belgium<br />
Economics<br />
Industrial<br />
technologies<br />
Innovation<br />
Medicine<br />
Economics<br />
Small and medium<br />
sized enterprise<br />
Molecular biology<br />
Telecom<br />
Strategy and<br />
Organisational<br />
Management<br />
Acknowledgments<br />
The Panel would like to<br />
thank all those who replied<br />
to <strong>the</strong> questionnaire, those<br />
who participated in hearings<br />
and, in general, those that<br />
have contributed to <strong>the</strong><br />
report with <strong>the</strong>ir comments.<br />
It takes this opportunity to<br />
thank <strong>the</strong> European<br />
Commission (EC), National<br />
Science Foundation and<br />
National Institute for Health<br />
programme managers who<br />
provided feedback, and, in<br />
particular, <strong>the</strong> EC staff that<br />
have provided support.<br />
7